Unknown

Dataset Information

0

Duodenal Fluid Analysis as a Rewarding Approach to Detect Low-Abundance Mutations in Biliopancreatic Cancers.


ABSTRACT: Diagnosis of biliopancreatic cancers by the available serum tumor markers, imaging, and histopathological tissue specimen examination remains a challenge. Circulating cell-free DNA derived from matched pairs of secretin-stimulated duodenal fluid (DF) and plasma from 10 patients with biliopancreatic diseases and 8 control subjects was analyzed using AmpliSeq™ HD technology for Ion Torrent Next-Generation Sequencing to evaluate the potential of liquid biopsy with DF in biliopancreatic cancers. The median cfDNA concentration was greater in DF-derived than in plasma-derived samples. A total of 13 variants were detected: 11 vs. 1 were exclusive for DF relative to the plasma source, and 1 was shared between the two body fluids. According to the four-tier systems, 10 clinical tier-I-II (76.9%), 1 tier-III (7.7%), and 2 tier-IV (15.4%) variants were identified. Notably, the 11 tier-I-III variants were exclusively found in DF-derived cfDNA from five patients with biliopancreatic cancers, and were detected in seven genes (KRAS, TP53, BRAF, CDKN2A, RNF43, GNAS, and PIK3CA); 82% of the tier-I-III variants had a low abundance, with a VAF < 6%. The mutational profiling of DF seems to be a reliable and promising tool for identifying cancer-associated alterations in malignant cancers of the biliopancreatic tract.

SUBMITTER: Tavano F 

PROVIDER: S-EPMC11312909 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Duodenal Fluid Analysis as a Rewarding Approach to Detect Low-Abundance Mutations in Biliopancreatic Cancers.

Tavano Francesca F   Latiano Anna A   Palmieri Orazio O   Gioffreda Domenica D   Latiano Tiziana T   Gentile Annamaria A   Tardio Matteo M   Latiano Tiziana Pia TP   Gentile Marco M   Terracciano Fulvia F   Perri Francesco F  

International journal of molecular sciences 20240802 15


Diagnosis of biliopancreatic cancers by the available serum tumor markers, imaging, and histopathological tissue specimen examination remains a challenge. Circulating cell-free DNA derived from matched pairs of secretin-stimulated duodenal fluid (DF) and plasma from 10 patients with biliopancreatic diseases and 8 control subjects was analyzed using AmpliSeq™ HD technology for Ion Torrent Next-Generation Sequencing to evaluate the potential of liquid biopsy with DF in biliopancreatic cancers. The  ...[more]

Similar Datasets

| S-EPMC10923589 | biostudies-literature
| S-EPMC4574535 | biostudies-literature
| S-EPMC6977685 | biostudies-literature
| S-EPMC11750664 | biostudies-literature
| S-EPMC3108827 | biostudies-literature
| S-EPMC2748083 | biostudies-literature
| S-EPMC11726417 | biostudies-literature
| S-EPMC8993124 | biostudies-literature
| S-EPMC4241379 | biostudies-literature
| S-EPMC4989483 | biostudies-literature